Global Remote Patient Monitoring Market Research Report - Segmented By Product (Vital Sign Monitors (Blood Pressure Monitors, Pulse Oximeters, Heart Rate Monitor (ECG), Temperature Monitor, Respiratory Rate, Monitor Brain Monitoring (EEG)), Special Monitors ( Anesthesia Monitors, Blood Glucose Monitors, Cardiac Rhythm Monitor, Respiratory Monitor Capnography, Spirometers ), Fetal Heart Monitors, Prothrombin Monitors, Multi-Parameter Monitors (MPM), Others); By Application (Cancer, Cardiovascular Diseases, Diabetes, Sleep Disorder, Weight management and Fitness Monitoring, Bronchitis, Infections, Eye infections, Sinus Infections, Strep Throat, Virus, Dehydration, Hypertension); By End-Use (Hospital-based Patients, Ambulatory Patients, Home Healthcare); and Region- Size, Share, Growth Analysis | Forecast (2024 – 2030)

Chapter 1. Remote Patient Monitoring Market – Scope & Methodology
1.1    Market Segmentation
1.2    Scope, Assumptions & Limitations
1.3    Research Methodology
1.4    Primary Sources
1.5    Secondary Sources
Chapter 2. Remote Patient Monitoring Market – Executive Summary
2.1    Market Size & Forecast – (2022 – 2030) ($M/$Bn)
2.2    Key Trends & Insights
           2.2.1    Demand Side
           2.2.2    Supply Side
2.3    Attractive Investment Propositions
2.4    COVID-19 Impact Analysis 
Chapter 3. Remote Patient Monitoring Market – Competition Scenario
3.1    Market Share Analysis & Company Benchmarking
3.2    Competitive Strategy & Development Scenario
3.3    Competitive Pricing Analysis
3.4    Supplier-Distributor Analysis 
Chapter 4. Remote Patient Monitoring Market - Entry Scenario
4.1    Regulatory Scenario
4.2    Case Studies – Key Start-ups
4.3    Customer Analysis
4.4    PESTLE Analysis
4.5    Porters Five Force Model
           4.5.1    Bargaining Power of Suppliers
           4.5.2    Bargaining Powers of Customers
           4.5.3    Threat of New Entrants
           4.5.4    Rivalry among Existing Players
           4.5.5    Threat of Substitutes 
Chapter 5. Remote Patient Monitoring Market – Landscape
5.1    Value Chain Analysis – Key Stakeholders Impact Analysis
5.2    Market Drivers
5.3    Market Restraints/Challenges
5.4    Market Opportunities 
Chapter 6. Remote Patient Monitoring Market – By Product 
6.1    Introduction/Key Findings   
6.2    Vital Sign Monitors
6.3    Blood Pressure Monitors
6.4    Pulse Oximeters
6.5    Heart Rate Monitor (ECG) 
6.6    Temperature Monitor 
6.7    Respiratory Rate 
6.8    Monitor Brain Monitoring (EEG)
6.9    Special Monitors
6.10    Anesthesia Monitors
6.11    Blood Glucose Monitors
6.12    Cardiac Rhythm Monitor 
6.13    Respiratory Monitor 
6.14    Capnography
6.15    Spirometers 
6.16    Fetal Heart Monitors
6.17    Prothrombin Monitors 
6.18    Multi-Parameter Monitors (MPM) 
6.19    Others
6.20    Y-O-Y Growth trend Analysis By Product 
6.21    Absolute $ Opportunity Analysis By Product , 2023-2030
Chapter 7. Remote Patient Monitoring Market – By Application
7.1    Introduction/Key Findings   
7.2    Cancer
7.3    Cardiovascular Diseases
7.4    Diabetes
7.5    Sleep Disorder
7.6    Weight Management and Fitness Monitoring
7.7    Bronchitis
7.8    Infections
7.9    Eye infections
7.10    Sinus Infections
7.11    Strep Throat
7.12    Virus
7.13    Dehydration
7.14    Hypertension
7.15    Y-O-Y Growth  trend Analysis By Application
7.16    Absolute $ Opportunity Analysis By Application, 2023-2030 
Chapter 8. Remote Patient Monitoring Market – By End-Use 
8.1    Introduction/Key Findings   
8.2    Hospital-based Patients
8.3    Ambulatory Patients
8.4    Home Healthcare 
8.5    Y-O-Y Growth trend Analysis By End-Use 
8.6    Absolute $ Opportunity Analysis By Distribution Channel, 2023-2030
Chapter 9. Remote Patient Monitoring Market , By Geography – Market Size, Forecast, Trends & Insights
9.1    North America
           9.1.1    By Country
                      9.1.1.1    U.S.A.
                      9.1.1.2    Canada
                      9.1.1.3    Mexico
           9.1.2    By Product 
           9.1.3    By Application
           9.1.4    By End-Use 
           9.1.5    Countries & Segments - Market Attractiveness Analysis
9.2    Europe
           9.2.1    By Country
                      9.2.1.1    U.K
                      9.2.1.2    Germany
                      9.2.1.3    France
                      9.2.1.4    Italy
                      9.2.1.5    Spain
                      9.2.1.6    Rest of Europe
           9.2.2    By Product 
           9.2.3    By Application
           9.2.4    By End-Use 
           9.2.5    Countries & Segments - Market Attractiveness Analysis
9.3    Asia Pacific
           9.3.1    By Country
                      9.3.1.1    China
                      9.3.1.2    Japan
                      9.3.1.3    South Korea
                      9.3.1.4    India      
                      9.3.1.5    Australia & New Zealand
                      9.3.1.6    Rest of Asia-Pacific
           9.3.2    By Product 
           9.3.3    By Application
           9.3.4    By End-Use 
           9.3.5    Countries & Segments - Market Attractiveness Analysis
9.4    South America
           9.4.1    By Country
                      9.4.1.1    Brazil
                      9.4.1.2    Argentina
                      9.4.1.3    Colombia
                      9.4.1.4    Chile
                      9.4.1.5    Rest of South America
           9.4.2    By Product 
           9.4.3    By Application
           9.4.4    By End-Use 
           9.4.5    Countries & Segments - Market Attractiveness Analysis
9.5    Middle East & Africa
           9.5.1    By Country
                      9.5.1.1    United Arab Emirates (UAE)
                      9.5.1.2    Saudi Arabia
                      9.5.1.3    Qatar
                      9.5.1.4    Israel
                      9.5.1.5    South Africa
                      9.5.1.6    Nigeria
                      9.5.1.7    Kenya
                      9.5.1.8    Egypt
                      9.5.1.9    Rest of MEA
           9.5.2    By Product 
           9.5.3    By Application
           9.5.4      By End-Use 
           9.5.5    Countries & Segments - Market Attractiveness Analysis 
Chapter 10. Remote Patient Monitoring Market – Company Profiles – (Overview, Product Portfolio, Financials, Strategies & Developments)
10.1    Koninklijke Philips N.V.  
10.2    Medtronic 
10.3    GE Healthcare 
10.4    Cerner Corporation 
10.5    Siemens Healthineers AG 
10.6    OMRON Healthcare 
10.7    Boston Scientific Corporation 
10.8    Abbott Laboratories 
10.9    Resideo Life Care Solutions 
10.10    Vivify Health, Inc. 

Download Sample

The field with (*) is required.

Choose License Type

$

2500

$

4250

$

5250

$

6900

Frequently Asked Questions

The Global Remote Patient Monitoring Market was estimated to be worth USD 26.32 billion in 2022 and is projected to reach a value of USD 103.73 billion by 2030.

Aging population growth and the expanding need for healthcare access to the market for remote patient monitoring and the market is driven by the high value of remote patient monitoring in containing infectious illnesses and epidemics are the factors driving the Global Remote Patient Monitoring Market.

The installation and training process for RPM is expensive, which will limit market expansion.

Vital sign monitor product type is the fastest growing in the Global Remote Patient Monitoring Market.

Asia-Pacific region is the fastest growing in the Global Remote Patient Monitoring Market.